Before I start, I will like to state that this short write up, similar to the opportunistic play on Capitaland on 30 Nov and Wilmar on 5 Oct, is to highlight an opportunistic play on Capitamalls Asia (“CMA”). This is based on technicals, and not an in depth analysis on CMA’s fundamentals. Worse STI component stock performance on a year to date (“YTD”) basis With reference to Table 1 below, it is apparent that CMA is the worst performer among the STI component stocks. However, this underperformance has also allowed it to have the highest potential capital gain (due to […]